Skip to main content
Kent Academic Repository

Aprotinin Inhibits SARS-CoV-2 Replication

Bojkova, Denisa, Bechtel, Marco, McLaughlin, Katie-May, McGreig, Jake E., Klann, Kevin, Bellinghausen, Carla, Rohde, Gernot, Jonigk, Danny, Braubach, Peter, Ciesek, Sandra, and others. (2020) Aprotinin Inhibits SARS-CoV-2 Replication. Cells, 9 (11). Article Number 2377. E-ISSN 2073-4409. (doi:10.3390/cells9112377) (KAR id:83961)

Abstract

Severe acute respiratory syndrome virus 2 (SARS-CoV-2) is the cause of the current coronavirus disease 19 (COVID-19) pandemic. Protease inhibitors are under consideration as virus entry inhibitors that prevent the cleavage of the coronavirus spike (S) protein by cellular proteases. Herein, we showed that the protease inhibitor aprotinin (but not the protease inhibitor SERPINA1/alpha-1 antitrypsin) inhibited SARS-CoV-2 replication in therapeutically achievable concentrations. An analysis of proteomics and translatome data indicated that SARS-CoV-2 replication

is associated with a downregulation of host cell protease inhibitors. Hence, aprotinin may compensate for downregulated host cell proteases during later virus replication cycles. Aprotinin displayed anti-SARS-CoV-2 activity in different cell types (Caco2, Calu-3, and primary bronchial epithelial cell air–liquid interface cultures) and against four virus isolates. In conclusion, therapeutic aprotinin concentrations exert anti-SARS-CoV-2 activity. An approved aprotinin aerosol may have potential for the early local control of SARS-CoV-2 replication and the prevention of COVID-19 progression to a severe, systemic disease.

Item Type: Article
DOI/Identification number: 10.3390/cells9112377
Uncontrolled keywords: severe acute respiratory syndrome coronavirus; severe acute respiratory syndrome coronavirus 2; 2019-nCoV; COVID-19; antiviral; drug discovery; aprotinin
Subjects: Q Science > QR Microbiology > QR355 Virology
R Medicine > RM Therapeutics. Pharmacology
Divisions: Divisions > Division of Natural Sciences > Biosciences
Depositing User: Martin Michaelis
Date Deposited: 06 Nov 2020 12:39 UTC
Last Modified: 15 Jun 2022 03:14 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/83961 (The current URI for this page, for reference purposes)

University of Kent Author Information

McLaughlin, Katie-May.

Creator's ORCID:
CReDIT Contributor Roles:

McGreig, Jake E..

Creator's ORCID: https://orcid.org/0000-0002-3068-5624
CReDIT Contributor Roles:

Wass, Mark N..

Creator's ORCID: https://orcid.org/0000-0001-5428-6479
CReDIT Contributor Roles:

Michaelis, Martin.

Creator's ORCID: https://orcid.org/0000-0002-5710-5888
CReDIT Contributor Roles:
  • Depositors only (login required):

Total unique views for this document in KAR since July 2020. For more details click on the image.